Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1(LOE Classification)
| Autor: | Logigian, E.L., Martens, W.B., Moxley, R.T., McDermott, M.P., Dilek, N., Wiegner, A.W., Pearson, A.T., Barbieri, C.A., Annis, C.L., Thornton, C.A., Moxley, R.T. |
|---|---|
| Zdroj: | Neurology (Ovid); May 2010, Vol. 74 Issue: 18 p1441-1448, 8p |
| Abstrakt: | To determine if mexiletine is safe and effective in reducing myotonia in myotonic dystrophy type 1 (DM1). |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|